Published

The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Frontiers in human neuroscience
Date: 2014-01-01
Source: PubMed
DOI: 10.3389/fnhum.2014.00204
PubMed: 24904346

Authors

Roseman L Leech R Feilding A Nutt DJ Carhart-Harris RL

Watch author

Derived topics and classifications

psilocybin Mechanism of Action Receptor Pharmacology Consciousness Healthy Volunteers Other

Citation graph

0 referenced DOIs found in stored source metadata. 8 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration2026-04-10 Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies2026-03-19 “Diversity makes the richness of humanity”: The emergence and persistence of mental imagery after self-reported psilocybin truffles intake in an autistic woman with “blind imagination” (aphantasia): A33-month retrospective case report2026-03-09 Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applications2026-03-01 Acute psilocin increased cortical activity in rat2026-02-04 Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice2022-02-23 Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience2021-09-01 The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.2014-01-01

Related papers

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 Investigation of Psychedelic Effects in Psychoactive SubstancesClinicalTrials.gov · 2026-02-23 Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2025-10-01 The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy TrainingClinicalTrials.gov · 2025-04-14